NEW DELHI: European approval for the Indian-made Covishield vaccine could be delayed, said Adar Poonawalla, CEO of vaccine manufacturer Serum Institute of India (SII). He estimated it would take about a month for approval. The European Medicines Agency (EMA) has not yet specified whether Covishield will be included in the European Union (EU) Digital COVID … Continue reading Uncertainty remains over Covishield vaccine as Serum Institute says European approval could be delayed; Indian Government intervenes to expedite the process